Cite

HARVARD Citation

    Beilman, C. et al. (n.d.). A104 COST-EFFECTIVENESS OF INFLIXIMAB BIOSIMILAR FOR THE MANAGEMENT OF CROHN'S DISEASE. Journal of the Canadian Association of Gastroenterology. p. 179. [Online]. 
  
Back to record